Linked Life Data

1415442

Source:http://linkedlifedata.com/resource/pubmed/id/1415442

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4 Pt 2
pubmed:dateCreated
1992-11-16
pubmed:abstractText
The most recent statistical evidence confirms a protective effect of oral contraceptive use against ovarian and endometrial cancers. Studies of the association between oral contraceptive use and cervical cancer continue to be hampered by confounding factors; however, results suggest that the overall risk of invasive cervical neoplasia is not increased. Although the association between oral contraceptive use and breast cancer remains controversial, existing data strongly suggest that overall risk of breast cancer is not increased by the use of oral contraceptives. In most candidates for oral contraceptive use, the benefits greatly outweigh the risks.
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Americas, http://linkedlifedata.com/resource/pubmed/keyword/Bias, http://linkedlifedata.com/resource/pubmed/keyword/Breast Cancer, http://linkedlifedata.com/resource/pubmed/keyword/Cancer, http://linkedlifedata.com/resource/pubmed/keyword/Case Control Studies, http://linkedlifedata.com/resource/pubmed/keyword/Cdc, http://linkedlifedata.com/resource/pubmed/keyword/Central America, http://linkedlifedata.com/resource/pubmed/keyword/Cervical Cancer, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods--beneficial..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Mode Of Action, http://linkedlifedata.com/resource/pubmed/keyword/Costa Rica, http://linkedlifedata.com/resource/pubmed/keyword/Developed Countries, http://linkedlifedata.com/resource/pubmed/keyword/Developing Countries, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/Endometrial Cancer--etiology, http://linkedlifedata.com/resource/pubmed/keyword/Error Sources, http://linkedlifedata.com/resource/pubmed/keyword/Europe, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Government Agencies, http://linkedlifedata.com/resource/pubmed/keyword/INTERNATIONAL AGENCIES, http://linkedlifedata.com/resource/pubmed/keyword/Latin America, http://linkedlifedata.com/resource/pubmed/keyword/Measurement, http://linkedlifedata.com/resource/pubmed/keyword/Neoplasms, http://linkedlifedata.com/resource/pubmed/keyword/North America, http://linkedlifedata.com/resource/pubmed/keyword/Northern America, http://linkedlifedata.com/resource/pubmed/keyword/Northern Europe, http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives..., http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives--beneficial..., http://linkedlifedata.com/resource/pubmed/keyword/Organizations, http://linkedlifedata.com/resource/pubmed/keyword/Ovarian Cancer--etiology, http://linkedlifedata.com/resource/pubmed/keyword/Ovulation Suppression, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology, http://linkedlifedata.com/resource/pubmed/keyword/Studies, http://linkedlifedata.com/resource/pubmed/keyword/Un, http://linkedlifedata.com/resource/pubmed/keyword/United Kingdom, http://linkedlifedata.com/resource/pubmed/keyword/United States, http://linkedlifedata.com/resource/pubmed/keyword/Usphs, http://linkedlifedata.com/resource/pubmed/keyword/Who
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9378
pubmed:author
pubmed:issnType
Print
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1171-6
pubmed:dateRevised
2007-11-15
pubmed:otherAbstract
PIP: The largest case control study on the association between oral contraceptive (OC) use and cancer is the US Cancer and Steroid Hormone (CASH) study. Since it did not use hospital-based patients as controls, it eliminated some biases. Since OCs suppress ovulation and suppressed ovulation is linked with reduced risk of ovarian cancer, scientists believe OCs may reduce this cancer risk. The CASH study shows that OC use indeed decreases the risk of ovarian cancer 40% (relative risk [RR]=.6 and this protection lasts for more than 10 years after OC discontinuation. Protection increases with duration of OC use (1 year RR=.6 and 10 years RR=.2). Estrogenic stimulation of the endometrium without ample progestational protection causes endometrial cancer. Thus combined OCs which have estrogen and progestin components should reduce the risk of endometrial cancer. The CASH study reveals OC use for at least 12 months reduces this risk 50%. OCs have a protective effect for at least 15 years after stopping OC use. In addition, UK national mortality data show OC use caused the decline in ovarian cancer mortality and a 40% decrease in endometrial cancer mortality over the last 20 years. A WHO 7-county case control study indicates that OC users in developing countries have the same protective effect against ovarian and endometrial cancer as those in developed countries. Studies of OC use and cervical cancer have had conflicting results due to 3 biases: cervical cancer is associated with sexual behavior and is therefore a sexually transmitted disease; detection bias. A study in Costa Rica conducted by CDC study has addressed the 1st and 3rd biases. It found no increased risk of invasive cervical cancer or carcinoma in situ with OC use. Studies of OC use and breast cancer have also had conflicting results, but the data clearly indicate that OC use does not increase the overall risk of breast cancer. In fact, OC benefits surpass breast cancer risks.
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Oral contraceptives and gynecologic cancer: an update for the 1990s.
pubmed:affiliation
University of Florida Health Science Center, Jacksonville 32209.
pubmed:publicationType
Journal Article, Review